Position in ACIU
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,179,806
-$750,887 QoQ
Shares Held
792,657
-15.1% QoQ
Ownership
0.779%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACIU Over Time
Shares Held
Position Value (USD)
Derivatives in ACIU
reported options exposure · as of Sep 30, 2025CallValue
$274,261
CallShares
94,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. ACIU ranks #243 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in ACIU
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,179,806 | 792,657 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,930,693 | 933,342 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,585,197 | 894,532 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $274,261 | 94,900 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $591,809 | 291,532 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $397,842 | 212,750 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $321,408 | 119,040 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $628,009 | 166,140 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $424,388 | 106,363 | Shares | Sole | 2024-08-14 | |
| 2023-06-30 | $152,277 | 51,532 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $295,500 | 100,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $278,523 | 119,027 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $221,964 | 108,806 | Shares | Sole | 2023-02-14 | |
| 2021-09-30 | $271,432 | 40,452 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $607,192 | 76,569 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,917,917 | 252,026 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $109,293 | 21,140 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $976,000 | 200,000 | Call | Sole | 2020-11-16 | |
| 2020-09-30 | $1,337,749 | 274,129 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,480,998 | 517,236 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,632,441 | 525,679 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||